Assemblify Ltd

Assemblify Ltd is a pioneering force in biotechnology research, dedicated to CNS drug discovery by design. Originating as a spin-out from the University of Leeds, Assemblify is driven by world-leading researchers and a commitment to innovation. The company’s novel off-the-shelf approach, utilizing functioning age-relevant models and blood-brain barrier prototypes, ensures robust and validated results.

Assemblify is focused on transforming ambition into tangible realities within the pharmaceutical sector. By leveraging cutting-edge technology and advanced research methodologies, Assemblify Ltd is positioned to make significant contributions to the development of new therapies. The company's dedication to excellence and innovative solutions sets it apart as a leader in the industry.

Assemblify continues to push the boundaries of biotechnology, driving advancements that promise to reshape the future of CNS drug discovery. The team is constantly working to refine and expand its capabilities, ensuring that Assemblify remains at the forefront of scientific progress. We invite the management team at Assemblify to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and reach within the market.